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ABSRACT
The bioarcheology and forensic anthropology literature describes the visual detection of
cancerous lesions on dry bone, including those that metastasize from soft tissues. While the field
of paleopathology has recently brought attention to use of radiographs in detecting cancerous
lesions, these developments have not become standard in forensic anthropology. The objective of
this study is to determine if the presence of cancer in a sample of contemporary skeletons is
detected more frequently when assessed using radiographs compared to simply macroscopic
examination of dry bone. Given the mechanisms of cancer metastasis, it is expected that more
cancerous lesions within the study sample would begin inside the bone, thus visible only with the
aid of medical imaging equipment. Potentially individuating cancerous lesions may not be
detected when employing only macroscopic analysis of dry bone and may be excluded from the
biological profile, impeding the identification of unknown remains.
The study sample consisted of 30 individuals with reported cancer from the William M.
Bass Donated Skeletal Collection. All elements were examined in isolation for the presence of
visible lesions following the criteria for differential diagnosis established in the paleopathology
literature (Ortner 2003; Roberts and Manchester 2005). Each element was also radiographed at
the University of Tennessee Student Health Center by a trained radiology technician. Dry bone
and radiographs were examined in isolation with statistical methods comparing the frequencies
of lesion detection assessing the strength of agreement between the methods.
Results show that more individuals displayed lesions radiographically compared to
macroscopically (63%), with 42% of those individuals exhibiting lesions only visible on the
radiographs. Of the elements selected, lesions appeared most frequently on the skull, followed by
the os coxae. Agreement between the methods ranged from slight to substantial, depending on
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the element under analysis, with substantial agreement occurring in elements when individuals
exhibited no lesions. Given these results, the argument can be made that radiographing skeletal
material is a necessity for detecting the full range of disease presence in a contemporary forensic
context.
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CHAPTER ONE
INTRODUCTION AND GENERAL INFORMATION

Cancer
Cancer is a disease that significantly impacts contemporary populations, with the World
Health Organization (2020) attributing one in every six deaths to cancer worldwide. In 2018,
cancer was estimated to cause 9.6 million deaths globally (World Health Organization 2020). In
addition to the deaths caused by cancer, the diagnosis and treatment of cancer can create social,
physical, and economic strains on the patient, their families, and their community. In the United
States alone, there were 1,658,716 new cases of cancer and 598,031 deaths due to cancer in
2016, the most recent year for which official federal records are available (U.S. Cancer Statistics
Working Group 2019). Of these new cases, the most diagnosed was female breast cancer at a rate
of 124.2 per 100,000 people, followed by prostate (101.4) and lung and bronchus cancer (56)
(U.S. Cancer Statistics Working Group 2019). In terms of deaths caused by cancer in 2016, the
leading cancer was that of the lung and bronchus at a rate of 38.5 per 10,000 people, followed by
female breast (20.0) and prostate (19.4). Cancer is the second leading cause of death in the
United States, with one in every four deaths being attributed to it. According to the United States
Cancer Statistics (2019), the rate of cancer has been steadily decreasing since 1999, however,
risk factors for cancer have been increasing, such as exposure to environmental carcinogens and
increased lifespans.
Also referred to as neoplasms, cancerous tumors are characterized by the uncontrollable
and abnormal spread and growth of tissue cells (American Cancer Society 2018: 1; Roberts and
Manchester 2005: 252). These neoplasms have the potential to be either benign or malignant. Of
1

concern to this study are malignant tumors, those that have the potential to spread beyond the site
of origin to other tissues. Soft tissue cancers, especially those of the breast, prostate, thyroid,
lung, and kidney, are likely to metastasize to bone. The nature of metastatic lesions on bone can
be either osteoblastic, resulting in bone formation, or osteolytic, resulting in bone destruction.
There are two forms of lytic lesions: 1) those that destroy the cancellous bone first, then work
their way outward to eventually destroy the cortex and produce a macroscopically visible lesion,
and 2) those that begin on the surface of the cortex and are visible using macroscopic
examination. Presently, studies of cancer in dry bone provide detailed descriptions of the lesion
morphology being noted for different types of metastatic cancers on a case-study basis (BiehlerGomez et al. 2019; Brunetti et al. 2017, Marks and Hamilton 2007).

Detection of Cancerous Lesions on Bone
The bioarcheology and forensic anthropology literature (Aufderheide and RodríguezMartin 2006; Ortner 2003; Roberts and Manchester 2005) details the visual detection of
cancerous lesions on dry bone, including those that metastasize from soft tissues. However, the
use of radiographs to examine skeletal material, until recently, has seldom been mentioned in the
literature. In the field of paleopathology, recent attention has been brought to the fact that visual
inspection alone is not enough to account for the true scope of a cancerous lesion (Marques et al.
2019; Villa et al. 2019). While the use of radiographs to detect cancerous lesions in skeletal
material has received increased attention within the field of paleopathology, the same rigor and
momentum has not permeated the forensic anthropology community. This is problematic since
one route for cancerous lesions in bone to form is from the inner cortical bone outward, thus
invisible without the aid of medical imaging equipment (Marques 2019). Rothschild and
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Rothschild (1995) remains the only systematic large-scale analysis of the presence of metastatic
cancer using macroscopic and radiographic methods. Their findings indicated that two-thirds of
all cancer cases within their sample would have been missed by visual inspection alone.
However, their study was limited to the Hamman-Todd collection, comprising individuals who
lived during the late 1800s. The 1920 mortality statistics issued by the Department of Commerce
Bureau of the Census stated that cancer caused 72,931 deaths at a rate of 83.4 per 100,000 people
that year (Steuart 1922: 40). That number is significantly lower than the 598,031 deaths
attributed to cancer in 2016 (U.S. Cancer Statistics Working Group 2019). Therefore, cancer is
more prevalent in today’s society than when the individuals in the Hamman-Todd Collection
were alive. Additionally, their results may not apply to a contemporary population living in a
vastly different environment and having access to treatment options, such as chemotherapy and
radiation therapy, that would not have been available during that time.
Today, multiple modality treatment that combines chemotherapy, radiation, and surgery
is standard practice (DeVita and Chu 2008). Research in the clinical sphere has illustrated that
chemotherapy and hormonal therapies used to treat certain soft tissue cancers, such as breast and
prostate can have negative impacts on bone. Some of these impacts include: accelerated bone
loss, lower bone mineral density, osteopenia, and pathological fractures (Vehmanen et al. 2001;
Hadji et al. 2009; Greep et al. 2003; Georgiou et al. 2011; and Holmes et al. 1994). While this
research has been conducted in the clinical sphere, no current study explicitly examines how
these treatments may alter the way lesions manifest on dry bone in an anthropological context. A
study using a contemporary collection is necessary to understand how many instances of cancer
may be missed using only visual inspection.
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Hypothesis
It is hypothesized that more individuals in this study sample will exhibit visible lesions
on the radiographs when compared to only macroscopic analysis. This is because lesions have
the potential to take a hematogenous route into the medullary cavity of long bones and the
spongy bone of flat bones, forming endocortical lesions. These endocortical lesions would begin
inside the bone and initially only be visible with the aid of medical imaging equipment. It is also
hypothesized that porous lesions visible on the outside of the bone may exhibit evidence of
increased trabecular bone destruction on the radiographs that exceeds the boundaries visible on
the surface.

Objective and Implications
The objective of this study is to determine if visible cancerous lesions within a sample of
contemporary skeletons are detected more frequently when assessed using radiographs compared
to macroscopic examination of dry bone. Detecting cancerous lesion presence in bone is
important because skeletal material is sometimes all that remains in forensic and archaeological
contexts. According to the United States Cancer Statistics (2019), the rate of cancer has been
steadily decreasing since 1999, but the risk factors for cancer have been increasing. If these
trends continue, cancer may become a more common occurrence in forensic investigations,
providing more potentially individuating lesions that can be incorporated into the biological
profile. Individuals that sought treatment for cancer may have antemortem scans on file that can
be compared to postmortem scans for positive identification purposes. In paleopathological and
archaeological contexts, cancer is often considered rare (Assis and Codhina 2010; Capasso 2005;
David and Zimmerman 2010). A study that allows for the full range of metastatic cancer
4

manifestations to be detected within a contemporary population is necessary to formulate better
methods of cancerous lesion detection in dry bone that can be incorporated into the biological
profile in forensic contexts.
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CHAPTER TWO
LITERATURE REVIEW

Cancer significantly impacts contemporary populations and exhibits a wide range of
variation in its manifestation. Generally, cancerous tumors are categorized as benign or
malignant. Benign tumors remain confined to the site of origin and exhibit well-differentiated
borders from the surrounding tissue, while malignant tumors consist of poorly differentiated
borders and may spread from the site of origin (Ortner 2003; Roberts and Manchester 2005).
Neoplasms can also be divided into primary or secondary tumors. Primary tumors are associated
with the tissue of origin, while secondary tumors originate in one tissue and metastasize to
another. Therefore, there is the potential for primary benign, primary malignant, and secondary
malignant tumors. The following subsections will discuss cancerous tumors that affect bone.

Primary Cancer
Primary bone cancers, those that are the result of uncontrolled growth and proliferation of
cells originating in bone, are generally rare and tend to occur in younger individuals (Ortner
2003). Osteomas are the most common form of benign tumor. There are three common types of
malignant primary bone neoplasms that each leave their own unique markers on the skeleton,
including: osteosarcoma, Ewing’s sarcoma, and chondrosarcoma (Fisher 2013). These tend to be
rare and occur in individuals 10-24 years of age (Fisher 2013).

Benign Cancers
The most common form of benign primary cancer is the osteoma, which consists of dense
lamellar bone on the outer surface of the bone, usually on the frontal and parietal bones of the
6

skull (Aufderheide and Rodríguez-Martin 2006; Brothwell 2008; Marques 2019). This form of
osteoma is usually referred to as a button osteoma. Osteoid osteomas also may occur, which
consist of a dense area of cortical bone with a center of osteoid and bone trabeculae (Aufderheide
and Rodríguez-Martin 2006; Brothwell 2008). The most common locations for these tumors
include the diaphysis of the femur, tibia, fibula, and humerus, as well as the vertebrae and tarsal
bones (Ortner 2003). Osteoid osteomas more often affect females and individuals within the
active growing period between the ages of 10-30 (Aufderheide and Rodríguez-Martin 2006).
However, it is possible for older individuals to be afflicted, though it is rare. Osteoblastomas are
another form of benign primary tumors that affect the thoracic and lumbar spine and the
diaphysis of long bones (Ortner 2003). However, they tend to affect individuals under the age of
20. Yet another form of primary benign tumor that affect individuals under the age of 20 is the
ossifying fibroma, which has the potential to affect the long bones (Aufderheide and RodríguezMartin 2006).

Malignant Tumors - Osteosarcoma
Osteosarcoma is the most common primary malignant bone tumor, accounting for 40-60%
of all primary malignant tumors (Hansen 2009). It arises from the connective tissue elements of
bone and is characterized by the production of osteoid (Hansen 2009). The most commonly
affected areas include the active growth sites in the metaphyses of the distal femur, proximal
tibia, and proximal humerus (Aufderheide and Rodríguez-Martin 2006; Ortner 2003). This
predilection for the metaphyses is due to abundant sinuses, blood supply, and a direct connection
between the epithelium and the tumor cells, all of which are necessary for tumor cells to
proliferate (Virk and Lieberman 2007). Males are more often affected than females and
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adolescents and young adults are more often affected (Ortner 2003; Hansen 2009). Osteosarcoma
is thought to arise from a mutation in p53 or retinoblastoma (Rb) genes, which would normally
suppress tumor growth. These mutations allow tumor cells to replicate without any sort of
restraint, producing growth factors such as Transforming Growth Factor (TGF), Insulin Growth
Factor (IGF), and connective tissue growth factor (CTGF), which leads to angiogenesis, the
formation of new blood vessels, of the tumor cells and more accelerated cell replication and
growth (Broadhead et al. 2011). These growth factors lead to increased osteoblast expression,
with osteoblasts being important mediators of bone resorption through their expression of
RANKL (Broadhead et al. 2011).
Like cancerous tumors that affect other tissues, osteosarcoma has the potential to
metastasize, with the osteosarcoma cell breaking away from the primary tumor, adhering to the
extracellular matrix (ECM), migrating via intravasation, and finding a new site via extravasation
(Broadhead et al., 2011). When assessing its appearance on dry bone, radiographs are necessary
to assess the level of cortical penetration achieved. Initial lytic activity within the metaphysis
results in alternating areas of osteopenia and normal density bone resulting a “cloudy”
appearance (Aufderheide and Rodríguez-Martin 2006). With increasing time, the lesion moves
outward towards the cortex. If cortical penetration is achieved, the result is a “sunburst”
appearance whereby spicules of new bone formation occur as surrounding structures are
penetrated, which may be visible without the aid of radiographs (Aufdherheide and RodríguezMartin 2006; Roberts and Manchester 2005). If the osteosarcoma began outside the bone
between the periosteum and cortical bone, rather than within the metaphysis itself, the
manifestation is different. The growing tumor can lift the periosteum, forming a Codman’s
triangle that demarcates the boundaries of the tumor (Aufderheide and Rodríguez-Martin 2006).
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There is also the possibility of these lesions becoming sclerotic following treatment, with
sclerotic areas of calcification occurring both within and outside the bone (Aufderheide and
Rodríguez-Martin 2006; Wu and Hochman 2012). This can be an indication of slowed tumor
growth and attempts by the bone to repair itself.

Malignant Tumors – Ewing’s Sarcoma and Chondrosarcoma
Ewing’s sarcoma arises from undifferentiated mesenchymal stem cells, forming a
permeative lesion that is loosely held together by matrix (Ortner 2003). This allows the lesion to
spread from the intertrabecular spaces to the outer cortex over a large surface area, eliciting a
bony response on the surface of the bone (Ortner 2003). While the most commonly affected
areas are the long bone extremities and the pelvic bones, other sites with trabecular marrow can
also be affected (Ortner 2003). Ewing’s sarcoma is differentiated from osteosarcoma in that it
does not produce osteoid or any other matrix. If reactive bone is present, distinguishing Ewing’s
sarcoma from osteosarcoma is accomplished by taking into account the permeative intracortical
destruction and the lack of involvement along the diaphysis (Ortner 2003). When assessing its
appearance radiologically, the formation of different lamellar layers may produce an “onionskin” appearance (Aufderheide and Rodríguez-Martin 2006). This condition occurs in children
and adolescents (Ortner 2003).
Chondrosarcoma arises in the metaphases of long bones, especially those of the proximal
and distal femur and the proximal humerus (Ortner 2003: 526; Roberts and Manchester 2005). It
is also important to note that bone metastases frequently originate within the bone and progress
outward to the cortical bone, thus producing endosteal scalloping of the cortex only visible with
the aid of medical imaging equipment (Ortner 2003; Roberts and Manchester; Marques 2019).
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There is no sex predilection and individuals from late-adolescence into adulthood are affected
(Ortner 2003).

Secondary Cancer
Cancers that arise in soft tissues and later spread to bone are more common within adult
populations. Five soft tissue cancers have a propensity to metastasize to bone include: breast,
prostate, thyroid, lung, and kidney (Coleman 1997; Coleman and Rubens 1987; Roberts and
Manchester 2005; Taxel and Mirza 2009). Breast and prostate are considered the most prevalent,
accounting for more than 65% of all skeletal metastases (Lukaszewski et al. 2017; Mundy 2002).
Skeletal lesions have also been attributed to bladder, pancreas, esophagus, and melanoma
cancers, though these are considered rare (Assis and Codhina 2010). Once a cancer metastasizes
to bone, it can become a major cause of morbidity and mortality for the patient with bone pain
being a common ailment (Jimenez-Andrade et al. 2010; Taxel and Mirza 2009; Macedo et al.
2017; Coleman 1997). Other problems associated with cancer metastases include pathological
fractures, anemia, impaired mobility, spinal cord compression, and hypercalcemia (JimenezAndrade et al. 2010; Macedo et al 2017; Coleman 1997; Taxel and Mirza 2009; Lukazewski et
al. 2017).

Mechanisms of Cancer Metastases
The propensity for cancers to metastasize to bone is tied to Stephen Paget’s 1889 “seed
and soil hypothesis” whereby the “microenvironment of the new organ serves as the fertile soil
for the cancer cells” (Gosman 2012). This idea was later challenged by James Ewing in the
1920s when he suggested a circulatory pattern between primary and secondary tumor sites, thus
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suggesting a mechanical route for cancer metastases (Chambers et al. 2002). This idea found a
resurgence in the 1940s when Batson noted a direct linkage between a group of veins in the
prostate and the capillary beds of the lumbar spine (Robinson et al. 2004). Both were correct in
their assumptions. Once a primary tumor invades the underlying tissue, the tumor cells can enter
the blood or lymph in a process known as intravasation, which allows them to circulate
throughout the body (Couzin 2003; Chambers et al. 2002). The anatomical nature of blood
vessels and capillaries may assist in the transmission of cancer cells from the primary site to the
secondary site. However, according to the “seed and soil” hypothesis, not all microenvironments
are suitable for the growth of metastatic cancer, therefore certain cancers can only metastasize to
particular sites, such as the bone marrow cavity (Macedo et al., 2017; Mundy 2002). Once an
ideal site is found, one of two processes may occur. The cancer cells may adhere to the blood
vessels and proliferate within them, or extravasation occurs, and the cancer cells begin to interact
with the endothelium of the new host site (Macedo et al., 2017; Robinson et al. 2004). Once in
the new site, proliferation and angiogenesis can occur (Couzin, 2003). As the cells constantly
divide, they cause inflammation via pro-inflammatory cytokines and growth factors and disrupt
various components including: cytoxic lymphocytes, macrophages, Tregs, and Th1/Th2 cells
(Curiel 2007). By causing inflammation, disrupting the immune system, and promoting the
development of new blood vessels, an ideal environment is maintained whereby the tumor cells
can continue to proliferate (Chambers et al. 2002).
Bone is an extremely “fertile” ground for cancer cells to grow and proliferate due to the
rich blood supply in the hematopoietic bone marrow, as well as the scaffold structure necessary
to support the growth of cells (Mundy 2009). As such, bones of the axial skeleton tend to be
affected more often, including: the vertebrae, proximal femur, ribs and sternum, skull, os coxa,
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sacrum, proximal humerus, and shoulder girdle (Aufderheide and Rodríguez-Martin 2006;
Ragsdale and Lehmer 2012; Binder et al. 2014; Assis and Codhina 2010; Coleman 2006;
Macedo et al. 2017). These areas of the skeleton were confirmed as preferred sites of breast
cancer metastases in a contemporary sample from the CAL Milano Cemetery Skeletal Collection
(Biehler-Gomez et al. 2019). Some uncommon sites of cancer metastases include the distal
elbow and knee due to their distance from the axial skeleton (Leeson et al. 1986). It is also
important to note that metastatic lesions on bone almost always tend to be multiple, with solitary
lesions being a rarity and associated with slow-growing cancers, such as chondrosarcoma
(Macedo et al. 2017; Ortner 2003). The nature of metastatic lesions can be either osteolytic,
resulting in bone destruction, osteoblastic, resulting in bone formation, or a mixture of the two.

Cancerous Lesions - Lytic
Some lytic metastases destroy the cancellous bone first, then work their way outward to
eventually destroy the cortex and produce a macroscopically visible lesion, while other lytic
lesions may begin on the surface of the cortex (Ortner 2003; Roberts and Manchester 2005; Wu
and Hochman 2012). Lytic lesions tend to be associated with cancers of the lung, thyroid, and
kidney (Ortner 2003; Roberts and Manchester 2005; Wu and Hochman 2012).
Lytic cancerous lesions are primarily the result of unchecked osteoclastogenesis, or the
formation of bone destroying osteoclasts, that would normally be balanced by osteoblastogenesis
(formation of bone-forming osteoblasts) in growth and remodeling. Therefore, an understanding
of the underlying cellular pathways that stimulate bone destruction is necessary. The primary
cellular pathway for this process is the OPG/RANK/RANKL pathway. Receptor Activator of the
Nuclear Factor Kappa – 𝛽 Ligand (RANKL) is a member of the Tumor Necrosis Factor (TNF)
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superfamily that is secreted by osteoblasts, osteocytes, bone lining cells, and other stromal cells
(Florencio-Silva et al. 2015; Iñiguez-Ariza and Clarke 2015). To stimulate osteoclast formation,
RANKL must bind to RANK (Receptor Activator of the Nuclear Factor Kappa – 𝛽) on osteoclast
precursor cells (Florencio-Silva et al. 2015). RANKL must also bind with Macrophage Colony
Stimulating Factor (M-CSF), which is secreted by mesenchymal cells and osteoblasts, for proper
stimulation of osteoclast expression (Florencio-Silva, 2015). The third piece of the
OPG/RANK/RANKL pathway is Osteoprotegerin (OPG), which is produced by bone lining
cells, osteoblasts, and stromal cells (Florencio-Silva et al. 2015). OPG acts as a decoy by binding
to RANKL instead of allowing RANKL to bind to RANK, which inhibits the cascade necessary
for osteoclastogenesis (Sherman 2012). For lytic cancerous lesions, a cycle is initiated, where
factors that are secreted by the tumor cell, such as Parathyroid Hormone Related Peptide
(PTHrP), Interleukins (IL-1 and IL-6), Prostaglandin E2 (PGE2), and Tumor Necrosis Factor
(TNF), promote bone resorption via RANKL (Macedo et al. 2017). As the bone is resorbed,
factors in the extracellular matrix (ECM), such as TGF-β, fibroblast growth factor (FGF),
insulin-like growth factor (IGF), and Bone Morphogenetic Protein (BMP-2) are released from
the bone matrix and promote growth of the tumor cells (Macedo et al. 2017). As tumor cells
grow, they secrete more factors that stimulate RANKL, further breaking the bone down,
releasing more factors that promote growth of the tumor cell. This creates a feedback loop that
highlights the unstoppable nature of soft tissue lytic cancer metastases to bone.
In addition to the OPG/RANK/RANKL pathway, the Wnt/β-Catenin signaling pathway is
of importance since it mediates the OPG/RANK/RANKL pathway by differentiating cells into
the osteogenic (bone forming) linage, allowing for osteoblastogenesis to occur. In instances of
cancer metastasis, this pathway is inhibited, thus allowing for the OPG/RANKL/RANK pathway
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and osteoclastogensis to go unchecked. There are many factors that inhibit the Wnt//β-Catenin
signaling pathway, including sclerostin, which is produced by the SOST gene in osteocytes and
tends to be overexpressed in breast cancer (Iñiguez-Ariza and Clarke 2015). Sclerostin acts as an
antagonist to the Wnt/β-Catenin signaling pathway by binding to Wnt co-receptors Lipoprotein
Receptor-related Protein (LRP) 5/6 in osteoblasts, thus preventing Wnt and LRP 5/6 from
binding to the Frizzled co-receptor complex (Iñiguez-Ariza and Clarke 2015). If Wnt cannot bind
to Frizzled, osteoblastogenesis is suppressed, leading to the enhancement of osteoclastogenesis
through increased osteoblast apoptosis (Bermeo et al. 2014). Dickkopf 1 (Dkk1) is another
factor produced by osteocytes that leads to increased osteoclastogenesis through the inhibition of
the Wnt signaling pathway in a similar fashion to sclerostin (Iñiguez-Ariza and Clarke 2015;
Brunetti et al. 2017).

Cancerous Lesions - Blastic
In contrast to lytic cancerous lesions, the cellular mechanisms surrounding osteoblastic
lesions are less understood. Osteoblastic lesions tend to appear as either rough, porous masses, or
as fine “spicules,” and tend to be associated with cancers of the prostate, uterus, and ovaries
(Ortner 2003; Roberts and Manchester 2005). The cellular mechanisms responsible for
osteoblastic lesions are thought to primarily be the result of factors such as endothelin-1, BMPs,
TGF-β2, FGF, RUNX2 and osteocalcin, which increases cancer cell proliferation and osteoblast
formation (Macedo et al. 2017; Mundy 2002, Esposito et al. 2018). For example, Endolthelin-1
was found in higher levels in individuals with prostate cancer and breast cancer that produced
osteoblastic metastases (Mundy 2002). Research suggests that osteoblasts are vital not only for
the normal regulation of bone homeostasis, but for maintaining the survival of cancer cells that
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metastasize to bone. Similar to the feedback seen in lytic lesions, osteoblasts secrete factors such
as PTHrP, VEGF, IL-6, and IL-8 that can be taken up by the cancerous tumor cells, thus
promoting a feedback cycle of growth and survival of tumor (Shupp et al. 2018). With time,
osteoblastic lesions can give way to lytic lesions as osteoblasts begin to produce more
inflammatory cytokines, including RANKL, which are vital for stimulating osteoclastogenesis
(Esposito et al. 2018; Shupp et al. 2018).

Cancerous Lesions – Mixed
Breast cancer produces a mixture of osteolytic and osteoblastic lesions (Aufderheide and
Rodríguez-Martin 2006). In breast cancer especially, the main mediator of osteoclast activation
is parathyroid hormone related peptide (PTHrP), which stimulates the binding of RANKL to
RANK and is found in elevated levels in individuals with breast cancer (Coleman 2006; Mundy
2002; McCauley and Schneider 2004). Increased expression of PTHrP also downregulates the
production of OPG, further promoting osteoclast formation and bone resorption (Gosman 2012).
While the lesions may be primarily osteolytic due to the stimulation of osteoclasts, increased
serum-alkaline phosphate levels, PTH, and PTHrP produce a local bone-forming response
adjacent to the lytic lesion (Mundy 2002; McCauley and Schneider 2004). Therefore, these
lesions can manifest as primarily lytic with blastic margins.

Differential Diagnosis of Cancerous Lesions
Assessment of Dry Bone
Significant portions of the paleopathology literature describe the macroscopic detection
of cancer on dry bone because of the propensity of primary cancers and soft tissue metastatic
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cancers to leave macroscopically visible lesions (Ortner 2003, Roberts and Manchester 2005;
Aufderheide and Rodríguez-Martin 2006). The characteristics of lesions are described, including:
whether the lesion is osteolytic, osteoblastic, or mixed; whether it is a solitary lesion multifocal;
whether the margins of the lesion show activity at the time of death; and whether their
distribution throughout the skeleton predilects the axial or appendicular skeleton or the diaphysis
or epiphysis of particular elements (Marques 2019). Specific lesions are commonly described
with descriptive terms, such as “sunburst appearance,” “Codman’s triangle,” and “onion-skin”
(Aufderheide and Rodríguez-Martin 2006; Ortner 2003; Roberts and Manchester 2005).
However, using radiographs to examine skeletal material, until recently, has seldom been
mentioned in the paleopathology literature.

Detection Using Radiographs
Roberts and Manchester (2005:253) claim that “ideally radiographic analysis should be
undertaken whenever possible to ensure that internal lesions are identified.” They further state
that visual inspection alone is not a reliable enough method to account for the true scope of
cancerous lesions. This is because metastatic cancers may begin in the marrow inside the bone,
not on the outside, and that “mere inspection may fail to reveal these deep truths, which may
only be demonstrated radiographically on bone” (Roberts and Manchester 2005: 261). A similar
sentiment has been echoed by Marques (2019: 645) who claims that “systematic radiographic
evaluation of bones with changes to the external surface is essential for diagnosis, as
intramedullary lesions may be discovered, and the differential diagnosis is also more reliable.”
Brothwell (2012), Ragsdale et al. (2018), and Villa et al. (2019) also advocate for the combined
macroscopic study of bones and radiographs whenever possible.
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Marks and Hamilton (2007) have also advocated for the use of combined gross
morphological examination and radiographic analysis in the differential diagnosis of metastatic
cancer in cases where differential diagnoses may overlap. Their study detailed the lesions present
in a 62-year old contemporary white female who did not seek any formal medical treatments for
her metastatic breast cancer. The use of radiographs allowed them to rule out multiple myeloma
as a potential diagnosis and clarify that metastatic breast cancer was the correct diagnosis. While
their case does use a contemporary example, the fact that this individual did not seek any sort of
treatment for her condition may not be an accurate representation of how cancerous lesions
manifest in contemporary remains.

Radiography
Radiographs offer many advantages, such as their ease of access and relatively low cost
when compared to other imaging modalities (Tins et al. 2009; Villa et al. 2019). However,
compared to other imaging modalities, bone destruction needs to be significant before it can be
visualized radiographically. Tins et al. (2009) estimate destruction needs to reach between 3075% of the bone mass before it can be noted on a radiograph. Therefore, lesions that manifest as
porosity without extensive cortical destruction may not appear on radiographic images. Despite
the requirement of substantial bone destruction, radiographs are more likely to be available to
forensic anthropologists and archaeologists than other imaging modalities, such as computed
tomography (CT) and Magnetic Resonance Imaging (MRI) (Villa et al. 2019).
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Radiography – Technical Notes
Radiographic images allow one to visualize the internal structures of the bone and can
highlight differences in densities easily. An X-ray machine consists of the X-ray tube, or the
source of the X-rays, and an image detector, usually a film, where the X-ray attenuation is
recorded and an image is produced (Villa et al. 2019). When reading a radiograph, the image will
be darkest where the greatest number of x-rays have permeated the image detector. Therefore,
empty spaces will be colored black and areas of lower density will be colored varying shades of
grey. The image will be lightest where more X-rays were absorbed by the sample, therefore the
most dense parts of bones would appear white (Villa et al. 2019).
There are many systems of classifying skeletal lesions on radiographs on living
individuals for risk of malignancy in the literature (Lodwick 1964; Madewell et al. 1981a,
1981b, 1981c; Miller 2008; Costelloe and Madewell 2013; Ragsdale and Lehmar 2012).
Ragsdale et al. (2018) has outlined a scoring system meant for radiographing dry bone specimens
that classifies cancerous lesions based on the nature of their borders that is a modified version of
the Lodwick-Madewell Grading System, which is commonly used in radiology to classify lytic
lesions in the living for risk of malignancy. Table 2.1 shows the scores and descriptions for the
modified Lodwick-Madewell Grading System present in Ragsdale et al. (2018), while Figure 2.1
illustrates these descriptions.

Uses for Radiographs Within Forensics
Medical imaging equipment has increasingly been employed in forensic pathology and
forensic medicine, especially in the growing trend known as the “virtual autopsy” or “virtopsy.”
Virtopsy is considered a noninvasive tool that can be used in conjunction with traditional autopsy
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or ultimately replace traditional autopsy in cases where religious or cultural taboos prohibit such
(Thali et al. 2006; Dirnhofer et al. 2006; Buck et al. 2009; Bollinger et al. 2008) The use of xray, CT, and MRI has been employed in forensics as an aid to traditional autopsy by allowing for
gas (such as in a pneumothorax), foreign bodies (such as bullets or shrapnel), and bone fractures
(such as in motor vehicle accidents) to be visualized prior to a traditional autopsy (Grabher et al.
2007; Bollinger et al. 2008). While Virtopsy has gained increasing acceptance in forensic
pathology and medicine, these methods are primarily used on fleshed remains. Therefore, these
methods have not received the same traction in an anthropological scenario where skeletonized
remains are found.
The use of medical imaging equipment during forensic anthropological analysis has
mostly involved the comparison of antemortem and postmortem radiographs for establishing
positive identification (Ross et al. 2016, Stephan et al. 2011, Watamaniuk and Rogers 2010), the
use of trabecular bone pattern as a means of identification (Kahana et al. 1998, Kahana and Hiss
1994), development of methods for estimating measurements from radiographic images or 3D
reconstructions of the skull (Schroeder et al. 1997, Verhoff et al. 2007), and methods of age or

Table 2.1 Scores and descriptions for Modified Lodwick-Madwell Grading System.
IA
Well-defined geographic lytic lesion with a sclerotic rim/margin
IB

Well-defined geographic lytic lesion with a sharp margin without a
sclerotic rim. The sclerotic rim fades and looks “punched out”

IC

The lesion extends between the trabeculae, covering a larger area.
Therefore, the margin is ill-defined.

II

“Moth-eaten” margins. The cortex has many overlapping lesions.

Permeative destruction. Margins not clearly defined.
III
(Ragsdale et al. 2018: 30).
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Figure 2.1 schematic illustrating the Modified Lodwick-Madwell Grading System (Ragsdale et
al. 2018, p.32, Figure 2. Originally from Ragsdale, 1993, p. 452, Figure 2).
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sex estimation based on radiographs (Aly et al. 2016; Garamendi et al. 2011; Wittschieber et al.
2013, Dedouit et al. 2010). However, the contributions of radiographs to the detection of disease
processes is not a prominent part of the forensic anthropology literature, despite mention in the
paleopathology literature. Lack of radiographing skeletal material could be due to many factors,
such as a lack of resources or misunderstandings surrounding the benefits of medical imaging
equipment (Biehler-Gomez et al. 2019). Despite these setbacks, the necessity of radiographing of
skeletal material has been addressed for cases of dental disease and for porotic hyperostosis
(Linn et al. 1987; Macadam 1987). Therefore, the value of radiographs to cancer detection
should be recognized.

Radiography and Cancer Detection
The need to radiograph skeletal material for the detection of cancerous lesions has
received attention within the paleopathology literature, however, this same attention has not
permeated the forensic sphere (Ortner 2003; Roberts and Manchester 2005; Brothwell 2012).
The necessity of radiographs was systematically tested by Rothschild and Rothschild (1995).
They visually examined the entire skeleton of 129 individuals with documented cancer in the
Hamman Todd Collection, documenting the form and distribution of bony lesions. They then
subjected the entire skeleton to radiographic analysis in a blind manner whereby previous
presence or absence of skeletal lesions visible were unknown. Their analysis indicated that of the
129 individuals examined, only 11 showed signs of cancer macroscopically but 33 individuals
exhibited cancer radiologically, mostly in the form of increased or decreased bone density
(Rothschild and Rothschild 1995: 358). Only four individuals exhibited lesions both
macroscopically and radiologically (Rothschild and Rothschild 1995). Therefore, if visual
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inspection alone was used to detect cancer, two-thirds of all cases would have been missed.
Another key observation in their study was that there was no notable relationship between the
distribution of metastatic diseases and the location of the primary soft tissue tumor, contrary to
what is noted macroscopically in the paleopathology literature (Rothschild and Rothschild 1995).
This observation justifies the need to radiograph the entire skeleton instead of selecting only a
few elements. The authors also found that 91% of radiographic metastases appeared on the ilia,
while femoral metastases were also noted in high frequencies (Rothschild and Rothschild 1995).
Therefore, if one were to select elements for x-ray due to time or budget constraints, the ilia and
femora should be considered. While the use of radiographs to detect cancerous lesions in
skeletal material has received increased attention within the field of paleopathology, the same
rigor and momentum has not been accepted within the forensic anthropology community,
primarily utilizing visual methods of detecting disease frequency.

Cancer in Contemporary Populations
With the exception of Rothschild and Rothschild’s (1995) study, no other large-scale
studies explicitly compared the presence of cancer lesions both macroscopically and
radiologically. However, their use of the Hamman-Todd Collection is not an accurate
representation of cancer prevalence in a contemporary population. The 1920 mortality statistics
issued by the Department of Commerce Bureau of the Census stated that cancer caused 72,931
deaths at a rate of 83.4 per 100,000 people that year (Steuart 1922: 40). That number is
significantly lower than the 598,031 deaths attributed to cancer in 2016 (U.S. Cancer Statistics
Working Group 2019). Researchers have addressed the topic of cancer in antiquity, and the
general consensus is that there is a lower frequency of malignant conditions in the past than there
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are in clinical practice today (Assis and Codhina 2010; Capasso 2005; David and Zimmerman
2010). This lack of cancer presence in antiquity can be due to many factors, including
differences in diet, life expectancy, and environment. These differences can also impact the way
cancers manifest in bone, therefore, a study utilizing a contemporary collection is of importance,
The modes of cancer treatment commonly employed today have rapidly advanced and
would not have been common practice when individuals in the Hamman-Todd Collection were
alive. The use of hormonal therapy to treat breast and prostate cancer was first employed in 1939
(DeVita and Chu 2008). Experimental treatments in the early 1940s included the use of nitrogen
mustard and folic acid (DeVita and Chu 2008). Chemotherapy, or the “use of chemicals to treat
cancer,” was not systematically employed until the mid-1960s with proof that childhood
leukemia and adult Hodgkins lymphoma could be cured (DeVita and Chu 2008). Today, multiple
modality treatment that combines chemotherapy, radiation, and surgery is standard practice
(DeVita and Chu 2008). In certain types of cancer, such as breast and prostate, hormone-based
therapies may also be employed, including ovarian ablation and androgen deprivation therapy
(Garlow 2007; Fraenkel et al. 2013; VanderWalde and Hurria 2011; Saad et al. 2008).
Clinical data has illustrated that chemotherapy and hormonal therapies used to treat
certain soft tissue cancers, such as breast and prostate can have negative impacts on bone. Some
of these impacts include accelerated bone loss, lower bone mineral density, osteopenia, and
pathological fractures (Vehmanen et al. 2001; Hadji et al. 2009; Greep et al. 2003; Georgiou et
al. 2011; and Holmes et al. 1994). This could be due to the chemicals used pushing bone marrow
stromal cells to an adiopogenic lineage instead of an osteoblastic lineage (Georgiou et al. 2012).
While much work has been done in assessing the clinical effects of contemporary cancer
treatments on bone in living patients, no current study explicitly examines how these treatments
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may alter the way lesions manifest on dry bone in an anthropological context. The advancements
in cancer treatments since the 1950s relegates earlier studies on cancer using collections
comprised of individuals born before 1920 as not representative of cancer prevalence in
contemporary populations. A study using a contemporary collection is necessary to truly
understand how instances of metastatic cancer are visualized on bone, and how many cases are
missed if visual inspection alone is employed.
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CHAPTER THREE
MATERIALS AND METHODS

This study compared recognition of cancer on skeletal material macroscopically and
radiologically to assess which method would more frequently detect cancerous lesions. The
visualization of cancer radiologically was considered because some cancerous lesions begin on
the inside of the bone due to the mechanisms of soft tissue cancer metastases. Therefore, it was
expected that if a lesion were to develop at all, it would first be visible radiologically. This
chapter will cover the process of selecting the study sample, as well as the methodologies
employed for both radiographic and visual assessment. Statistical tests used to compare the
frequencies of lesion presence and agreement between the methods will be described.

Sample
The study sample for this project was drawn from the William M. Bass Donated Skeletal
Collection housed at the University of Tennessee. A spreadsheet of all donors with reported
cancer was generated from the collection database, resulting in a list of 139 individuals with
general cancer presence reported, such as “cancer” or “metastatic cancer.” Within this group of
139, a list of 55 individuals with specific cancers reported, such as breast or prostate cancer was
also generated. A power analysis utilizing the chi-squared test was conducted in R. The chisquared test was chosen because it measures goodness of fit and was appropriate for the data
being examined. Based on the literature regarding skeletal metastases and identification of
lesions using both radiographs and macroscopic examination, the difference in lesion detection
between radiographic examination and macroscopic examination would exhibit a difference
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between 0-34% of the time. If this holds true for this study sample, would 30 donors be enough
to capture that difference? The significance level was set at 0.05. The results of the power
analysis determined that a sample of 30 donors would have at least 76.6 power to identify the
difference in lesion detection between differing methods. Thus, a sample of 30 individuals was
selected from the generated lists at random to include fifteen male and fifteen female individuals
over the age of 40 and having reported soft tissue cancers.
Given the nature of the research question, a control group of individuals without reported
cancer was not sampled. All donors received an anonymized number (1-30) as an attempt to
avoid cognitive bias. Table 3.1 lists the sex, age, and reported cancer within the study sample.
Elements selected for analysis from each donor included: the cranium, mandible, all vertebrae,
sacrum, clavicles, scapulae, sternum, ribs, humerii, os coxae, and femora. The radii, ulnae, tibiae,
fibulae, and bones of the hands and feet were excluded from analysis due to not being common
sites of soft tissue cancer metastasis (Aufderheide and Rodriguez-Martin 2006; Coleman 2006;
Ortner 2003; Roberts and Manchester 2005).

Assessment of Visible Lesion Presence
Radiological Assessment
Selected elements from each donor were radiographed at the University of Tennessee
Student Health Center by a radiology technician. Radiographs were chosen over computed
tomography due to both budget constraints and that radiographs are generally more accessible
than other medical imaging modalities. Radiograph images taken included: an anterior-posterior
(AP) view of the cranium, a lateral view of the left side of the cranium, superior-inferior views of
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TABLE 3.1 Sex, age, and reported cancer for study sample
Anonymized
Sex
Age
Cancer Reported
Number
1
Male
67
Lung
2
Female
65
Breast with metastases
3
4
5
6
7
8

Female
Female
Female
Male
Female
Male

62
52
68
57
40
82

Lung with metastases to brain and bone
Lung
Breast with metastases
Prostate with metastases
Breast
Prostate with lymph-node

9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

Female
Male
Male
Male
Male
Male
Female
Male
Male
Female
Female
Female
Male
Male
Female
Female
Male
Male
Female
Female
Male
Female

65
79
74
68
59
53
70
56
56
54
76
67
67
72
60
67
59
48
72
55
82
51

Lung
Lung
Lung
Metastatic
Prostate
Lung
Breast
Lung
Prostate with metastases
Lung
Lung with brain metastases
Breast with metastases
Lung
Lung
Breast with metastases
Lung
Cancer, metastatic
Lung
Lung
Lung
Prostate
Breast with metastases
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Figure 3.1 Illustration of post-cranial elements arranged to avoid element overlap.

the mandible, vertebrae, and ribs, posterior-anterior (PA) views of the sacrum and scapulae, and
AP views of the clavicles, sternum, humerii, os coxae, and femora. Cranial images were taken in
isolation, while the remaining elements were arranged on the image receptor in a way that
simultaneously minimized the number of images necessary while allowing for no elements to
overlap. Figure 3.1 provides an example of how post-cranial elements were arranged on the
image receptor.
As per the Bass Collection protocol, the cervical, thoracic, and lumbar vertebrae are
strung together in anatomical order. These elements were left in this state to allow different
vertebrae to be easily sequenced and identified by number. Images were taken by a trained
radiology technician at the exposure settings she decided were appropriate on a case by case
basis. This allowed for the exposure setting to be adjusted for each round of radiographs to
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prevent over or underexposure. The angles at which the images were taken were chosen to allow
for a clear view of the inner trabecular bone where the red bone marrow would have been in life.
While these angles allowed for significant portions of the elements to be analyzed, there were
drawbacks. One such issue was the presence of processes on certain elements overlapping other
parts of that element (ie. acromial process of scapula). The chosen angles also precluded
visualization of certain portions of elements to distinguish lesions, such as the lamina of the
vertebrae or portions of the ischiopubic rami of the os coxae. It is recommended that future
studies take multiple angles of skeletal elements if time and budgets allow. Digital images were
stored on a CD-rom burned by the radiology technician. Syngo FastView, a standalone viewer
for DICOM images, allowed for the contrast and lighting of the images to be altered, certain
parts of images to be analyzed more closely, and measurements of lesions to be taken.
The radiographs were visually analyzed by the author to determine the presence and
location of any lesions. The nature of the lesions (osteolytic, osteoblastic, or mixed), whether the
lesions were solitary or multifocal, and location of the lesions were recorded in an excel file
compatible with SAS software. Additional pathology notes for each donor detailed the nature of
the margins surrounding each lesion, the location of the lesion in relation to other lesions, the
size of the lesion, any other noticeable attributes of the lesion, and the presence of non-cancerous
pathological conditions such as arthritis or healed fractures. The nature of the margins
surrounding the lesion was assessed using the criteria outlined in Ragsdale et al. (2018: 30).
Refer to table 2.1 for a description of Ragsdale et al. (2018) Modified Lodwick-Madwell
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Grading system. Radiographic analyses were conducted prior to the macroscopic assessment of
visible lesions.

Visual Assessment
Following assessment of the radiographs, skeletal elements were examined
macroscopically for the presence of visible lesions. This analysis occurred one week after
radiographic analysis as an attempt to avoid cognitive bias. Ideally, the waiting period between
each analysis would have been longer, however, time constraints prohibited such. Visual analysis
followed the criteria for differential diagnosis established in the paleopathology literature (Ortner
2003, Roberts and Manchester 2005; Aufderheide and Rodríguez-Martin 2006). Such analyses
describe the characteristics of the lesion, such as whether it is lytic or blastic, whether it is
solitary or multiple, whether there is active bone formation around the margins, and where within
the skeleton the lesions are distributed as an attempt to narrow down the pool of potential disease
processes that could have produced the lesion in question. Nature of the lesions (osteolytic,
osteoblastic, or mixed), whether the lesions were solitary or multiple, and location of the lesions
were recorded in an excel spreadsheet compatible with SAS software. Additional pathology
notes for each donor detailed the nature of the margins surrounding each lesion, the location of
the lesion in relation to other lesions, the size of the lesion, the degree of cortical destruction, and
other distinguishable features of the lesions. Other observable pathological conditions, such as
arthritis and healed fractures, were also noted. An example of the data collection spreadsheet is
in Appendix A.
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Simultaneous Assessment
Following observation of both the radiographs and dry bone in isolation, the selected
elements were re-analyzed using both methods simultaneously. This analysis occurred one week
after visual assessment to avoid cognitive bias. Simultaneous assessment clarified why
discrepancies between macroscopic and radiographic assessment occurred. Discrepancies
between number of lesions seen macroscopically and radiologically were attributed to either the
angle of the radiograph not allowing a particular lesion to be seen, the condition being too small
of an area of bone formation or destruction to be able to be visible on radiographs, or the lesion
being located in an area of bone already of a lesser density, thus not apparent on the radiograph
in isolation. New notes were taken for each donor during this assessment, so that any differences
in observer opinion between isolated and simultaneous analysis could be assessed.

Statistical Methods Employed
Statistical analyses were based on the donor sample size of thirty (30) instead of
individual lesion counts. All statistical tests were completed in SAS v 9.4 (Cary, NC). Frequency
counts and percentages of lesion presence, lesion nature and lesion location were acquired using
the Frequency procedure. Agreement between macroscopic and radiographic methods for each
element were conducted using the “agree” option within PROC FREQ and the Landis and Koch
(1977) scale for Kappa values, outlined in Table 3.2. This analysis was run for all elements, such
as comparing the lesion presence of the right clavicle macroscopically and radiographically, or
the lesion nature of the left os coxa macroscopically and radiographically. Fisher’s Exact Chisquare tests were conducted to assess the association between lesion detection using macroscopic
analysis and radiographic analysis.
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Using both statistical methods and detailed pathology notes, this study compared the
frequency of recognizing cancer macroscopically and radiographically to determine if more
lesions could be visualized using macroscopic examination, radiographic examination, or a
combination of both. Agreement between the methods was assessed, as well as reasons for
disagreement between the two methods, to provide a framework for detecting cancer presence in
skeletal remains within a contemporary context.

TABLE 3.2. Landis and Koch (1977) Kappa Statistic Agreements
Kappa Statistic

Strength of Agreement

<0.00

Poor

0.00-0.20

Slight

0.21-0.40

Fair

0.41-0.60

Moderate

0.61-0.80

Substantial

0.81-1.00

Almost Perfect
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CHAPTER FOUR
RESULTS

The results of this study indicate that identifiable lesions varied between the methods of
analysis and between the elements studied. Overall, more lesions were identified
radiographically compared to macroscopically. Simple Kappa and Fischer’s Exact Tests assessed
the agreement between radiographic and macroscopic analysis, indicating agreement to range
from slight to substantial depending on the element under analysis, with substantial agreement
occurring where no lesions were identified macroscopically or radiologically. The high levels of
disagreement between the two methods suggest that employing macroscopic examination alone
will not capture the full scope of lesion presence. Therefore, radiographing skeletal material, in
conjunction with macroscopic analysis of dry bone, within a forensic context is recommended to
accurately detect cancerous lesions on bone.

Lesion Frequencies
Within the sample of 30 individuals, lesions were noted either macroscopically or
radiographically in 19 individuals (63%), while 11 (37%) individuals exhibited no lesions. The
possibility of no lesions being observed is expected due to the nature of reporting soft tissue
cancers. Just because a soft tissue cancer is reported does not necessarily indicate that the cancer
metastasized to the bone. When isolated macroscopic and radiographic analyses for those
individuals that exhibited lesions was compared, more individuals exhibited lesions that could be
visualized with radiographs overall (100%). Figure 4.1 illustrates lesion presence frequencies for
all elements for those individuals with lesions present (N = 19). More individuals exhibited
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Figure 4.1 Lesion Presence Frequencies Separated by Element (N = 19 Donors).

lesions on radiographs compared to macroscopic analysis on: the skull, left ribs, left clavicle,
right and left os coxae, and right and left femora. More individuals were observed as having
lesions present macroscopically, compared to radiographically, on the vertebrae, sacrum,
sternum, right ribs, right clavicle, right and left scapulae, and the right and left humerii (Figure
4.1). Potential error can be introduced when considering actual lesion counts when assessing
radiographic images. Radiographs show overlap of anterior and posterior surfaces in an AP view,
which may result in multiple visible lesions on dry bone assuming the appearance of a single
lesion on radiographs. Given the potential for these errors, assessing lesion visualization in terms
of “presence” and “absence” was used. Therefore, if a humerus exhibited one lesion or three
lesions, the notation of “lesion present” would be constant.
Figure 4.2 illustrates an example of a cranium that exhibited visible lesions using
macroscopic analysis of the dry bone and the radiographs. However, due to the overlap of the
parietals and frontal bones, more lesions would appear visible on the radiograph than on the dry
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Figure 4.2 Donor 2 lateral cranium radiograph (upper left) and photo (upper right), and anteriorposterior cranium radiograph (lower left) and photograph (lower right) of cranium with white
arrows indicating visible lesions.

bone when viewing the cranium from the same angle.
Of the donors that exhibited lesions radiographically, 42% exhibited lesions solely on the
radiographs, while 58% exhibited lesions through both macroscopic and radiographic analysis.
Table 4.1 lists lesion presence for all individuals, both macroscopically and radiographically, as
well as in which elements there was disagreement. If an individual is noted as “yes” lesion
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Table 4.1 Lesion presence for 30 individuals using both methods
Macroscopic Lesion
Radiographic Lesion
Element(s) where methods
Individual
Presence
Presence
disagreed
1
No
Yes
Skull
2
Yes
Yes
Clavicles, humerii
3
Yes
Yes
Skull, left femur
4
No
Yes
Skull
5
No
No
None
6
Yes
Yes
Vertebrae, skull
7
No
No
None
8
No
Yes
Skull, right os coxa
9
No
No
None
10
No
No
None
11
Yes
Yes
Os coxae
12
No
No
None
13
No
No
None
14
No
No
None
15
Yes
Yes
Right scapulae and clavicle
16
No
No
None
17
Yes
Yes
Right humerus, 1st ribs
18
Yes
Yes
Skull, sacrum
19
Yes
Yes
Skull, sacrum
20
No
Yes
Skull
21
Yes
Yes
Os coxae
22
Yes
Yes
Skull, os coxae, vertebrae
23
No
No
None
24
Yes
Yes
Vertebrae, sternum, scapulae
25
No
No
None
26
No
Yes
Skull
27
No
No
None
28
No
Yes
Skull
29
No
Yes
Os coxae
30
Yes
Yes
Vertebrae, sacrum, sternum,
os coxae, skull, femora.
*When there were discrepancies between the methods, the skull was the element in question
12 times (40%), the os coxa six times (23%), the vertebrae four times (13%), the sacrum
three times(10%), the humerii, femora, clavicles, scapulae, and sternum two times (6%).
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present, that indicates that a lesion was found on any of elements studied. Therefore, an
individual with one lesion or 20 lesions would still be marked as “yes.” When there was
disagreement between the methods, the elements were more likely the skull (40%) and the os
coxae (23%), followed by vertebrae (13%), sacrum (10%), humerii (6%), femora (6%), scapulae
(6%), clavicles (6%), sternum (6%), and 1st ribs (3%) (Table 4.1).

Other Lesion Attributes
Of the lesions detected in this study, more individuals exhibited visible lesions that were
lytic in nature, when compared to blastic. Of the lytic lesions, more were observed overall using
radiographs (60%), particularly on the skull and os coxae. Of the blastic lesions observed, only
one lesion of a questionable etiology was observed macroscopically, while two individuals
exhibited areas of increased density radiographically. However, the nature one of lesions is
uncertain, while the other was deemed cancerous. Locations of lesions also varied between the
methods. Unsurprisingly, more individuals exhibited lesions radiographically in areas of better
visibility (cranial vault, sternal body, and ilia), while more individuals exhibited visible lesions
macroscopically in areas that are difficult to see on radiographs (basicranium, vertebral arches,
acromion and coracoid process of scapulae, etc.).

Agreement Between the Methods
A Kappa agreement was conducted to assess the strength of agreement between
macroscopic and radiographic methods. Table 4.2 illustrates the results of the Kappa agreement
for lesions visually identified between macroscopic and radiographic methods. There were more
individuals with agreement between macroscopic and radiographic assessment when lesion
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presence was considered “absent,” with as many as 27 individuals having no lesions visible
using either method on the left femur. All skeletal elements showed more instances of
individuals having disagreement over lesion presence than agreement over the lesion being
“present” (Table 4.3). Highest agreement for lesions visualized as present between the methods
occurred in the sacrum (4), while the least agreement occurred in the skull (14). Clearly,
agreement between the two methods vary by individuals and by skeletal elements.
A Simple Kappa Agreement was conducted to assess the strengths of agreement of lesion
observation for all elements. Table 4.3 outlines the results of this test and assesses strength of
agreement using Landis and Koch (1977) (refer to table 3.2 for Landis and Koch criteria).

Table 4.2 Kappa agreement for lesion presence between macroscopic and radiographic
methods
agree present
agree absent
disagree
Skull
3
13
14
Cervical vertebrae
1
23
6
Thoracic vertebrae
2
23
5
Lumbar vertebrae
2
23
5
Sacrum
4
21
5
Sternum
2
22
6
Right ribs
2
20
8
Left ribs
1
22
7
Right clavicle
1
26
3
Left clavicle
1
26
3
Right scapula
2
22
6
Left scapula
2
23
5
Right humerus
0
26
4
Left humerus
1
25
4
Right os coxa
4
17
9
Left os coxa
3
18
9
Right femur
0
26
4
Left femur
0
27
3
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Table 4.3 Simple Kappa Agreements for lesion presence using macroscopic and
radiographic methods
Standard
95% Confidence
Estimate
Error
Limits
min
max
overall
0.2077
Fair agreement
0.1022
0.0075
0.4080
skull
0.1498
Slight Agreement
0.1057
-0.0573
0.3569
Cervical vertebrae
Thoracic
0.4718
Moderate Agreement
0.1602
0.1578
0.7859
Vertebrae
Lumbar vertebrae 0.4275
Moderate Agreement
0.1844
0.0661
0.7889
Sacrum
Sternum
0.3662
Fair Agreement
0.1824
0.0086
0.7238
Right ribs
0.3931
Fair Agreement
0.1760
0.0481
0.7380
Left ribs
Right clavicle
0.6429
Substantial Agreement
0.2299
0.1923
1.0000
Left clavicle
0.6407
Substantial Agreement
0.2338
0.1825
1.0000
Right scapula
0.4231
Moderate Agreement
0.1456
0.1377
0.7084
Left scapula
Right humerus
Left humerus
0.4470
Moderate Agreement
0.1596
0.1342
0.7598
Right os coxa
Left os coxa
Right femur
Left femur
*Any value with a “-“ denotes a rare event, thus the statistic could not be run

-

Depending on the element, agreement between the methods varied, ranging from slight to
substantial. Most notable was the substantial agreement between the methods for the clavicles
and slight agreement for the skull. A closer examination of why these agreement strengths vary
is warranted. In six individuals (32% of the sample), lesions were observed radiographically and
not macroscopically in the skull, thus producing slight agreement (Table 4.4). However, when
assessing the clavicles, agreement is high because 26 individuals (92.86% of the sample),
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exhibited no lesions using either method. Therefore, the agreement was because of the high
absence of lesions, not agreement over the presence of lesions.
Given this study’s small sample size, a Fisher’s Exact Chi-Square test was considered
appropriate to assess agreement of lesion detection between macroscopic and radiographic
assessment. Table 4.4 outlines the results of the Fisher’s Exact test for lesion presence between
macroscopic and radiographic examination. A P-value of <.05 is considered significant under
this test. The results of this analysis show that there is a significant difference between detection
of lesions using macroscopic and radiographic methods overall, and for all elements except the
cervical vertebrae, right humerus, and right femur.

Table 4.4 Fischer’s exact test for lesion presence agreement between macroscopic and
radiographic lesion presence
Probability
Pr <= P
Overall
0.0107
0.2016
Skull
0.0365
0.3342
Cervical vertebrae
0.0828
0.3655
Thoracic vertebrae
0.0001
0.0004
Lumbar vertebrae
0.0026
0.0128
Sacrum
0.0002
0.0003
Sternum
0.0046
0.0377
Right ribs
0.0009
0.0128
Left ribs
0.0004
0.0069
Right clavicle
0.0046
0.0138
Left clavicle
0.0044
0.0202
Right scapula
0.0013
0.0026
Left scapula
0.0002
0.0004
Right humerus
0.0621
0.0690
Left Humerus
0.0010
0.0025
Right os coxa
0.0001
0.0052
Left os coxa
0.0007
0.0191
Right femur
0.9000
1.0000
Left Femur
*Any value with a “-“ denotes a rare event, thus the statistic could not be run
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CHAPTER FIVE
DISCUSSION

The results of this study reflect the complexity in identifying whether a lesion is visible in
unbiased viewing of either dry bone or radiograph images. Whether an instance of reported
cancer that metastasizes to bone is visible is influenced by a multitude of factors. Some of these
issues include: the angle at which the radiograph was taken, the overall complexity of the
skeletal element being imaged, the amount of cortex destroyed by a lytic lesion, and the
distribution of lesions throughout the element as either localized or diffuse. The results of this
study indicate poor agreement between the methods in detecting lesions, with more than half of
the study sample exhibiting visible lesions that were missed if macroscopic analysis of dry bone
alone is employed. This contemporary study sample exhibited results not entirely different from
Rothschild and Rothschild (1995), with similar proportions of lesions being noted on radiographs
compared to macroscopically. Overall, the high levels of disagreement between the two methods
suggest that employing macroscopic examination alone will not capture the full scope of lesion
presence. Therefore, radiographing skeletal material, in conjunction with macroscopic analysis
of dry bone, within a forensic context is recommended to accurately detect cancerous lesions on
bone.

Lesion Frequencies
The results of this study indicate that visible lesions were noted on 63% of the study
sample, which was composed only of individuals with reported cancer. It should be remembered
that not all soft tissue cancers metastasize to the bone. Therefore, it was expected that in
selecting a sample of individuals with reported cancer, there would be individuals in this study
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that exhibited no lesions using either method. While there were individuals in this sample that
did not exhibit visible lesions, it should be remembered that roughly 70% of patients with
advanced prostate and breast cancer develop skeletal metastases (Coleman 1997, Saad et al.
2008). Therefore, the proportion of individuals within this sample with skeletal lesions is similar
to clinical reports and could be representative of a contemporary population.
More individuals in this study sample exhibited visible lesions radiographically for the
cranium, left ribs, left clavicle, right and left os coxae, and right and left femora while more
individuals exhibited lesions macroscopically for the vertebrae, sacrum, sternum, right ribs, right
clavicle, right and left scapulae, and the right and left humerii (Figure 4.1). When the complexity
of the bone in question is considered, these results appear clearer. Save for the cranium, elements
where more lesions were noted radiographically are relatively simple and were able to be viewed
easier on the radiographs. This is because they either lacked excessive processes, laid flat on the
image receptor, or lacked areas of dramatic density differences. Other elements that had
excessive processes or areas of thin bone were difficult to capture clearly in the radiograph and
exhibited more lesions viewable macroscopically. The reasons for the distribution throughout the
right and left halves of the body are unknown, as there is no mention in the literature of
metastatic cancers predilecting one side of the body over another. Without information
pertaining to location of any soft-tissue lesions prior to skeletonization (ie. lung cancer in the
right lung), the reasons for this distribution cannot be ascertained.
Of the donors that exhibited lesions on radiographs, 42% exhibited lesions solely on the
radiographs not visible macroscopically, while 58% exhibited lesions macroscopically, with
additional lesions being noted using the aid of radiographs. Therefore, macroscopic examination
alone did not capture the full range of visibly detectable lesions within the sample, validating

42

statements that radiography is necessary for the detection of internal lesions (Roberts and
Manchester 2005, Marques 2019).

Case Studies
Donor three exhibited no visible lesions that would indicate cancer during macroscopic
analysis. The only noticeable pathologies included a button osteoma on the occipital and
roughened porosity scattered throughout the vertebrae and ribs. Upon radiographic analysis, four
noticeable areas of radiolucency were noted on the cranium. Three of these were concentrated on
the frontal near midline and ranged from ~2-11mm in diameter. The margins of these defects
were gradual and followed a 1C classification according to Ragsdale et al. (2018)’s modified
Lodwick-Madewell Grading System. The fourth area of radiolucency was located on the inferior
frontal, was ~4mm in diameter, and exhibited gradual 1C margins. Figure 5.1 illustrates both the
dry bone and radiographs of the cranium for donor three.

Figure 5.1 Donor 3 cranium radiograph (left) and dry bone (right), with white arrows illustrating
the presence of lesions only visible on the radiographs.
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Donor two exhibited instances of lytic cancerous lesions throughout the dry bone on the
cranium, mandible, clavicles, right and left scapulae, multiple vertebrae, multiple ribs, the
sacrum, and the right and left os coxa. Figure 5.2 illustrates some examples of these lytic lesions.
Donor two, however, only exhibited signs of diffuse periosteal reaction along the diaphysis of
the right humerus when macroscopic analysis was employed. Periosteal reaction does not
automatically indicate cancer as there are multiple etiologies that can be linked to periostitis,
such as infection, nutritional deficiencies, and trauma. Therefore, in an unbiased viewing of the
dry bone the periostitis was noted but not considered a cancerous lesion. Radiographic analysis,
on the other hand, exhibited multiple lytic lesions throughout the cortex of the diaphysis on the
right humerus. Figure 5.3 illustrates the right humerus dry bone and radiographs, illustrating the
presence of additional lytic lesions not seen on the dry bone. This case provides an example of
how radiographs can detect additional lesions within the cortex, even in cases where there may
be excessive lytic lesions visible on the dry bone of other skeletal elements. The use of
radiographs in this case aided in understanding the scope of these cancerous lesions, especially

Figure 5.2. Donor 2 right os coxa (far left), right scapula (middle), and lateral view of the
cranium (far right) with white arrows illustrating visible lesions.
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Figure 5.3. Donor 2 right humerus bone (top) and radiograph (bottom) with white arrows
illustrating lesions visible on the radiograph throughout the shaft that are not visible on the dry
bone.

since the humeral diaphysis is not considered a common site of soft tissue cancer metastases
(Ortner 2003).
Donor 21 exhibited a large lytic lesion on the right os coxa near the auricular surface. The
lesion spanned ~31mm and exhibited porous and dark-colored margins. The anterior cortical
bone and underlying trabecular bone were destroyed, leaving the posterior cortical bone with
small pinprick-sized holes of porosity. The right os coxa illustrated grey-colored diffuse porosity
around the iliac fossa and along the obturator foramen on the dry bone. Upon radiographic
examination, the lytic lesion near the auricular surface spaned ~35mm, indicating that the lesion
extended additional millimeters underneath the cortex. An additional lesion was noted on the
radiographs near the anterior inferior iliac spine that measures ~17mm and exhibits gradual 1C
margins. This case highlights how radiographs can detect additional lesions on the same element
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Figure 5.4. Donor 21 right os dry bone (left) and radiograph (right) with arrows indicating lytic
lesions present.

where there are already macroscopically visible lesions. Figure 5.4 illustrates the presence of an
additional lesion on the right os coxa of donor 21, exhibiting how lesions can still be missed
If macroscopic analysis alone was employed. As the above three case studies have shown, the
use of radiographs was necessary to visualize the full range of cancerous manifestations in these
this study sample. This illustrates that even in cases where there are visible lesions on the bone,
the true nature of the cancerous metastasis may be more complicated and more extensive,
warranting further analysis.

Other Lesion Attributes
Of the 19 donors that exhibited visible lesions, five were males with reported lung cancer,
four were females with reported breast cancer, seven were females with reported lung cancer,
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and three were males with reported prostate cancer. These trends are not atypical, given that
lung, breast, and prostate are considered among the top five cancers that metastasize to bone
(Ortner 2003). More lesions noted were lytic in nature, which corresponds with the attributes of
the soft tissue cancers noted in the literature (Ortner 2003, Roberts and Manchester 2005, Wu
and Hochman 2012). There was one instance of a blastic lesion noted. The amount of lytic
lesions within this study sample should not be surprising given the cellular mechanisms of cancer
metastases where osteoblastic and osteoclastic responses may be coupled. Certain growth
factors, such as TGF-β2 and FGF, can initially promote osteoblastic lesions in cases of prostate
cancer. Those same growth factors can be taken up by the tumor cell itself, leading to secretion
of factors that stimulate RANKL, further breaking the bone down, releasing more factors that
promote growth of the tumor cell. This creates a feedback loop that highlights the unstoppable
nature of soft tissue lytic cancer metastases to bone. Therefore, even in cases of cancer that are
typically reported as being blastic in the literature, such as breast and prostate cancer, lytic
lesions may form if the cancer persisted long enough. This should highlight the importance of
considering the influence of contemporary medical interventions on the manifestation of
cancerous conditions in dry bone. The aid of contemporary cancer treatments prolongs the
timeline of cancer manifestations and can provide more time for lytic lesions to develop in
conditions that would have previously been considered blastic.
As noted in the results, variation in detection of lesions occurred within the same
elements, with more lesions being noted radiographically in areas of better visibility (the cranial
vault or the ilia), while clear macroscopic lesions were not visible on radiographs in areas of
elements that are difficult to capture in A-P radiographs. These shortcomings should prompt
future studies to radiograph material from multiple angles and ensure all portions of the elements
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Figure 5.5. Donor 15 basicranial view of dry bone (far left), lateral radiograph (middle) and AP
radiograph (far right), with white arrow indicating a visible lytic lesion on the dry bone.

are visible. Figure 5.5 illustrates an example of an instance where multiple angles would be
beneficial. There is a sizeable lytic lesion on the base of the occipital, however, this lesion is not
captured when only an A-P and lateral view of the skull is taken. One can see in the radiograph
image that the dense areas of the skull, such as the petrous portion of the temporals, obscures a
clear view of the lesion occurring in the basicranial areas. A superior-inferior radiograph of the
skull would be recommended in future studies. Figure 5.6 illustrates a case of a lesion in a
location that is difficult to see using either method. The lytic lesion occurs in the posterior body
of the first sacral segment. The lesion is of the median sacral crests overlapping the body. This
same issue occurs on the radiograph when taking a posterior-anterior view. To accurately see the
lesion on the dry bone, the bone itself needed to be angled so one is viewing into the sacral
canal. Therefore, an A-P view and an oblique angle should also be taken in addition to the P-A
radiograph.
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Figure 5.6. Donor 18 sacrum with a close-up view of lytic lesion in the sacral canal indicated by
white arrow (top image), radiograph (bottom left) and dry bone (bottom right).
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Agreement Between the Methods
Overall, the agreement between macroscopic and radiographic methods of lesion
detection was poor. When there was agreement, it was because a lesion was marked as “absent.”
When lesions were viewed as present, there were disagreements between the methods. When a
Simple Kappa Agreement was conducted to assess the strength of agreement, the results ranged
from slight to substantial. As mentioned in the results chapter, the substantial agreement
occurred in the clavicle where the agreement was due to lesion being marked “absent.” The
slight agreement between the methods for the detection of lesions in the skull was due to more
lesions being detected radiographically than macroscopically. The results of the Fisher’s Exact
Test for lesion presence showed that there is a significant difference between detection of lesions
using macroscopic and radiographic methods overall, and for all elements except the cervical
vertebrae, the right humerus, and the right femur. The reasons the agreement for the cervical
vertebrae, right humerus, and right femur are once again due to agreement over lesions being
“absent” as opposed to present. The propensity for disagreement between the methods reflects
that simply employing macroscopic analysis cannot account for the full range of skeletal
manifestations of metastatic cancer. If it could, the agreement between macroscopic and
radiographic assessment would be more similar. Since they are not in exact agreement,
radiographing skeletal material is necessary.

Simultaneous Assessment
Following isolated analysis of the dry bone and radiographic images, all skeletal elements
were analyzed simultaneously using both methods. Due to the introduction of this bias,
agreement between the methods improved with lesions not previously noted on radiographs
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being now visible. Throughout the course of the simultaneous assessment, a few noticeable
patterns emerged as to why there was such high disagreement between the two methods. Due to
the time and budget constraints of this project, multiple angles of skeletal elements were not
taken, which would affect whether lesions are visible. An example would be that more
individuals exhibited lesions macroscopically on the vertebrae, especially on the lamina. These
lamina lesions are not apparent in an A-P view of the vertebrae. Another example would be that
in taking a P-A view of the scapula, the spine and acromion process would obscure lesions on the
supraspinous fossa. There were also instances of disagreement within the same element, such as
the os coxae, where lesions on the ilium could be seen easily on radiographs while lesions on the
ischiopubic ramus or pubis could not. Figure 5.7 illustrates a case where the porous lesion on the
ilium could be visualized with radiographs, but the porous lesions near the obturator foramen
were better visualized using macroscopic analysis due to A-P views of os coxae not being able to
capture the iliopubic and ischiopubic rami.

Figure 5.7. Donor 11 right os coxa dry bone (far left and middle images) and radiograph (far
right image) with white arrows illustrating visible lesions.
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Another factor that could influence visibility of lesions radiographically is that not
enough of the cortex was destroyed to be visible on radiographic images, as with lytic lesions
that manifest as porosity without extensive cortical destruction. Very few lesions noted within
the study sample destroyed significant portions of the cortex, while more lesions were pockets of
increased, dark-colored porosity. This was apparent especially in thin elements, such as the
scapulae, where the radiolucency of the image is already high and could further obscure the
presence of porous lesions. There were also instances where the porosity was more diffuse and
spread throughout the element instead of forming a localized area of porosity. When the porosity
was diffuse, it appeared like normal, internal bone on the radiographs.
Figure 5.8 illustrates an example where lesions on the posterior right scapula manifested
as slightly grey-colored porosity, especially along the scapular spine, superior angle, medial and
lateral borders, and inferior angle. Lesions also manifested as porosity on the anterior surface of

Figure 5.8 Donor 17 right scapula posterior view of dry bone (far left), anterior view of dry bone
(middle), and posterior radiograph (far right), with arrows indicating visible porous lesions.
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the right scapula as grey-colored porosity, especially at the inferior angle. The posterior-anterior
view of the radiograph pictured illustrates how an element with thin portions may not provide the
contrast necessary to see porous lesions.

Potential Conflicts
As with any research project, there are inherent limitations to this project. The study
sample came from individuals who self-reported the presence of cancer. Without official medical
records, one does not know the details of their diagnosis, including whether skeletal metastases
were known. As with any population, the potential for comorbidities exists within this sample.
The individuals within this study sample are over the age of 40 and are prone to other conditions,
such as osteoporosis, that could possibly alter the integrity of the trabecular bone, thus distorting
the results of radiographic analysis. While some comorbidities are more apparent, such as
arthritis, healed fractures, or Schmorl’s nodes, others are not as apparent. There were multiple
instances in the pathology notes that questionable lesions were noted. This was especially the
case when porosity was diffuse throughout the element or appeared in an area unexpected given
the literature on cancer metastases. Some of these comorbidities could include infections or
injury that induce inflammation at the site, resulting in an osteoclastic response similar to a
cancerous lesion. Figure 5.9 illustrates an example of diffuse porosity on an ilium that is not
visible on radiographs. Diffuse porosity is often attributed to a multitude of etiologies, including
infection and nutritional deficiencies (Ortner 2003). Since the porosity is not visible on the
radiograph, details about the etiology may not be able to be elaborated.
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Figure 5.9 Donor 24 right os coxa radiograph (upper left) dry bone (upper right) and closeup of
periosteal bone reaction (lower) illustrated by arrows.
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Case Study
There were also instances where ambiguous lesions were clarified based on radiographic
assessment. Donor 30 exhibited a single lesion during macroscopic analysis,
consisting of a thick, roughened coating of porous bone on the shaft of the left first rib. The
entire length of the rib was surrounded by this roughened bone formation, with some areas
becoming as thick as ~12mm. Figure 5.10 illustrates both the dry bone and radiograph of this rib.
The particular etiology of this lesion is unknown as it does not appear typical of a healed
fracture. Upon radiographic analysis, the skull, thoracic and lumbar vertebrae, sacrum, right and
left ribs, right and left os coxa, and right and left femur exhibited small, circular clusters of
increased radiodensity. These lesions are characteristic of internal osteoblastic lesions and were
only visible with the aid of medical imaging equipment. Therefore, the use of radiographs
clarified that there were cancerous lesions present within this individual, thus providing a
potential etiology to the blastic rib lesion. Figure 5.11 provides an illustration of these
osteoblastic lesions only visible on radiographs. In this case, radiographs provided additional
information to accompany an ambiguous case. While the lesion on the rib may not be able to
conclusively be attributed to cancer, the presence of cancerous lesions throughout other portions
of the skeleton does make the diagnosis of cancer for the rib lesion more likely.

Sensitivity and Specificity
Instances such as the above highlight the importance of improving lesion detection
methods. With the implementation of radiographs, more lesions were being noted and attributed
to cancer, which added to the sensitivity, or true positive rate, of the study sample. Sensitivity
and specificity are concepts that are commonly employed in epidemiology, however, they are
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difficult to employ in paleopathological contexts. Sensitivity refers to the true positive rate, or
the “proportion of people with a condition who are correctly identified by a test as having the
condition” (Buikstra 2019: 15). When using skeletal samples, sensitivity is limited due to the fact
that not every condition having the potential to affect bone actually manifests as a visible lesion
(Buikstra 2019). In the case of metastatic cancer, an individual may have breast cancer that
remained localized to the breast and did not metastasize to the bone. Specificity refers to the true
negative rate, or the “proportion of people without a condition who are correctly identified by the
test as not having it” (Buikstra 2019: 15). When using skeletal samples, specificity is limited due
to bone being able to respond to multiple diseases in one of three ways: bone resorption, bone
formation, and a mixture of the two. Therefore, lesions with different etiologies may have a
similar appearance, resulting in false positives (Buikstra 2019). Examples of this encountered
within the study sample include elements with diffuse periostitis that could be attributed to other
conditions. By implementing radiographs into the analysis of dry bone for the detection of
cancerous lesions, a broader range of manifestations can be accounted for and added to the
identification criteria for cancerous lesions, thus increasing the sensitivity.

Results of Using a Contemporary Collection
Rothschild and Rothschild (1995) indicated that of the 26% of their sample that exhibited
lesions radiographically, only 3% exhibited lesions using both methods. The present study’s
sample, though much smaller, exhibited a higher percentage (37%) of individuals with lesions
visible using both methods of analysis. In Rothschild and Rothschild (1995), 23% of their sample
exhibited lesions solely using radiographs, whereas 42% of the current study’s sample exhibited
lesions solely using radiographs. Despite the smaller sample size, the proportions of individuals
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Figure 5.10. Donor 30 left first rib radiograph (left) and dry bone (right) exhibiting an ambiguous
case of excessive bone formation (indicated by arrows)

Figure 5.11 Donor 30 right os coxa radiograph (upper left) and dry bone (upper right), lumbar
vertebra radiograph (lower left) and dry bone (lower right). The arrows in both images illustrate
the presence of osteoblastic cancerous lesions.
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displaying lesions on radiographs not encountered macroscopically are similar. However, the
present study’s sample exhibited more instances where radiographs added to the nuance of
visible lesion presence in elements where there were already macroscopically visible lesions.
Therefore, it can be argued that radiographing skeletal material for cancer presence is necessary
for contemporary populations. Another finding that was similar to Rothschild and Rothschild
(1995) was that the current study sample contained more individuals that exhibited lesions
radiographically on the ilia and femora, however, the present study sample also contained more
individuals that exhibited visible lesions radiographically on the cranium, which was not a
finding in Rothschild and Rothschild (1995). The reasons for this difference are unknown.
Given the nature of the donation process for the Bass Collection, the individuals that
comprised the study sample may have had access to contemporary cancer treatments, such as
chemotherapy, radiation therapy, surgery, or hormonal therapies that would not have been
available to individuals in the Hamman-Todd collection. Clinical data has illustrated that
chemotherapy and hormonal therapies used to treat certain soft tissue cancers, such as breast and
prostate can have negative impacts on bone. Some of these impacts include: accelerated bone
loss, lower bone mineral density, osteopenia, and pathological fractures (Vehmanen et al. 2001;
Hadji et al. 2009; Greep et al. 2003; Georgiou et al. 2011; and Holmes et al. 1994). Given the
influence that cancer treatments have on the proliferation of cancer cells, either prohibiting the
spread of metastases or prolonging the process longer for more metastases to form, it is
surprising that the proportion of individuals within this study displaying lesions on radiographs is
like that of Rothschild and Rothschild (1995). These results support that radiographing skeletal
material for instances of disease presence should be a necessary part of any contemporary
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forensic investigation, since macroscopic analysis fails to capture the full range of manifestations
of cancer presence.

Further Implications
Cancer is the second leading cause of death in the United States, with one in every four
deaths being attributed to it. According to the United States Cancer Statistics (2019), the rate of
cancer has been steadily increasing since 1999. If these trends continue, cancer will continue to
play a pivotal role in contemporary society. This study has illustrated how an understanding of
cancer can be beneficial in multiple contexts. This study can have implications for forensic
contexts since cancer is a more individuating pathological condition that can be added to the
biological profile when compared to other conditions, such as arthritis. Individuals that sought
treatment for cancer may have antemortem scans on file that can be compared to postmortem
scans for positive identification purposes. This study has also illuminated that the use of medical
imaging equipment can also aid in clarifying ambiguous cases of disease presence, with
additional noncancerous, potentially individuating conditions also being captured with the aid of
radiographs. By increasing the range of manifestations of metastatic cancer, the sensitivity of
cancerous lesions within the sample also increased.
Beyond forensics, this study can also have paleopathological implications in that a fuller
understanding of how metastatic cancers manifest in contemporary remains may impact the way
cancer is understood in past populations as well. Researchers have addressed the topic of cancer
in antiquity, and the general consensus is that there is a lower frequency of malignant conditions
in the past than there are in clinical practice today (Assis and Codhina 2010; Capasso 2005;
David and Zimmerman 2010). This lack of cancer presence in antiquity can be due to many
factors, including differences in diet, life expectancy, and environment. However, these
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differences may also be due to the intricate process of soft tissue metastasis in bone. Clinical
studies have illustrated that contemporary medical interventions may have adverse effects on
bone, including: accelerated bone loss, lower bone mineral density, osteopenia, and pathological
fractures (Vehmanen et al. 2001; Hadji et al. 2009; Greep et al. 2003; Georgiou et al. 2011; and
Holmes et al. 1994). While much work has been done in assessing the clinical effects of
contemporary cancer treatments on bone in living patients, no current study explicitly examines
how these treatments may alter the way lesions manifest on dry bone in an anthropological
context.
This study has examined contemporary skeletal material for instances of cancer
metastasis, and has highlighted some interesting observations, including: instances of lesions
visible radiographically that were not visible macroscopically, additional lesions visible on
radiographs that were not visible macroscopically on elements already exhibiting
macroscopically visible lesions, lesions visible radiographically in areas that are not commonly
considered sites of soft tissue cancer metastasis, and lytic lesions manifesting in cancer cases
where lesions are typically blastic or mixed. This study sample has the benefit of consisting of
individuals with reported cancer, which allows for detailed examination of how lesions
manifested within specific forms of cancer. Therefore, this study could provide information
pertaining to the patterns of soft tissue metastasis specific to contemporary contexts.
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CHAPTER SIX
CONCLUSIONS AND RECCOMENDATIONS

Cancer is a disease which significantly impacts contemporary populations, with the
World Health Organization (2020) attributing 1 in every 6 deaths to cancer worldwide. In 2018,
cancer was estimated to cause 9.6 million deaths globally (World Health Organization 2020). In
addition to the deaths caused by cancer, the diagnosis and treatment of cancer can create social,
physical, and economic strains on the patient, their families, and their community. According to
the United States Cancer Statistics (2019), the rate of cancer has been steadily increasing since
1999. This is due to many factors, such as improvements in screening methods, exposure to
different environmental risk factors, and increased lifespans. If these trends continue, cancer will
continue to play a prominent role in contemporary society.
In the field of paleopathology, recent attention has shown that visual inspection alone is
not enough to account for the true scope of a cancerous lesion (Marques 2019; Ortner 2003;
Roberts and Manchester 2005; Brothwell 2012). While the use of radiographs to detect
cancerous lesions in skeletal material has received increased attention within the field of
paleopathology, the same rigor and momentum has not permeated the forensic anthropology
community. This is especially surprising given the rise of virtual autopsy within forensic
pathology and forensic medicine. The results of this study indicated that radiographing skeletal
material was a necessity to capture the full manifestation of metastatic soft tissue cancer presence
in bone. This sample exhibited poor agreement between the methods in assessing lesion
presence, with more than half of lesions being missed if macroscopic analysis of dry bone alone
is employed. The levels of agreement between the two methods ranged from slight to substantial,
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with substantial agreement only occurring in instances where the agreement was showing lesions
being absent. Therefore, macroscopic analysis alone cannot accurately capture disease presence.
This contemporary study sample exhibited results not entirely different from Rothschild and
Rothschild (1995), with similar proportions of lesions being noted on radiographs compared to
macroscopically. This indicates that even with contemporary influences, such as advancements
in cancer treatment, lesions permeating the inner cortex are being missed without the aid of
medical imaging equipment. Radiographing skeletal material for instances of potentially
individuating disease presence should be a necessary part of any forensic investigation.

Recommendations and Future Research
Future studies should radiograph skeletal material from multiple angles if time and
budgets allow to ensure that all areas of the element are visible. Images should be taken and
viewed by a trained radiology techologist when available. This study should also highlight the
importance of properly training forensic anthropologists in the imaging and interpretation of
radiographs, since a trained radiology technologist may not always be available. If possible,
future iterations of this study should employ the use of commuted tomography (CT) to assess
lesion presence due to the inherent benefits of this imaging modality. One such benefit is that
lesions lacking 30-75% of cortical destruction that would otherwise not be visible on a
radiograph might be visible using CT (Tins et al. 2009). Another benefit would be the ability to
compare anthropological CT scans and the information obtained from them to those that were
obtained in a virtual autopsy or antemortem CT scan context. This may allow for clarification in
how many lesions are clearly visible only in skeletonized material. Studies of this nature can
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provide a framework for visualizing potentially individuating lesions and contribute to a detailed
biological profile that aids in victim identification.
While this study has the benefit of comprising of individuals with reported cancer, a more
ideal sample would have complete medical histories that include the timing of the cancer onset,
the length of time the disease persisted, and any medical treatments received to provide a more
nuanced understanding of any contemporary interventions employed that could influence lesion
visibility. Having more complete medical histories would allow for lesion distributions to be
mapped across individuals with specific types of cancer. Clinical studies have illustrated that
contemporary medical interventions may have adverse effects on bone, including accelerated
bone loss, lower bone mineral density, osteopenia, and pathological fractures (Vehmanen et al.
2001; Hadji et al. 2009; Greep et al. 2003; Georgiou et al. 2011; and Holmes et al. 1994). While
much work has been done in assessing the clinical effects of contemporary cancer treatments on
bone in living patients, no current study explicitly examines how these treatments may alter the
way lesions manifest on dry bone in an anthropological context. Future research can expand
upon this idea and analyze skeletal collections from both pre and post-chemotherapy periods. A
nuanced understanding of the relationship between treatment options and the cellular
mechanisms that allow for soft tissue metastases to bone can aid in diagnosing cancer in dry
bone in both forensic and paleopathological contexts.
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ID Sex
1 male

2 Female
3
4
5
6
7

Female
Female
female
Male
Female

8
9
10
11
12
13
14
15
16
17
18

male
female
Male
male
male
Male
Male
female
male
male
Female

19 Female

Age Cancer
67 lung

65 breast with metastases
lung, metastatic to brain and
62 bone
52 Lung
68 breast with metastases
57 Prostate with metastases
40 Breast
Prostate and LymphNode
82 Cancer
65 lung
79 Lung
74 lung
68 metastatic
59 prostate
53 Lung
70 breast
56 lung
56 metastatic prostate cancer
54 Lung
lung cancer with brain
76 metastases

MGenLes MGenNat MSkullLesion MSkullNat MSkullNum MSkullLoc
No
N/A
No
N/A
N/A
N/A
occipital (~2), right parietal
(~10), left parietal (~14),
spheNoid, frontal (~12),
Yes
Lytic
Yes
Lytic
Multiple
mandible (~2).
Maybe
No
No
Yes
No

Lytic
N/A
N/A
Mixed
N/A

No
No
No
No
No

N/A
N/A
N/A
N/A
N/A

N/A
N/A
N/A
N/A
N/A

N/A
N/A
N/A
N/A
N/A

No
No
No
Yes
No
No
Yes
Yes
No
Yes
Yes

N/A
N/A
N/A
Lytic
N/A
N/A
Mixed
Mixed
N/A
Lytic
Lytic

No
No
No
No
No
No
No
Yes
No
Maybe
No

N/A
N/A
N/A
N/A
N/A
N/A
N/A
Mixed
N/A
Lytic
N/A

N/A
N/A
N/A
N/A
N/A
N/A
N/A
Multiple
N/A
Multiple
N/A

N/A
N/A
N/A
N/A
N/A
N/A
N/A
vault, occipital
N/A
spheNoid, frontal, mandible
N/A

Yes

Lytic

No

N/A

N/A

N/A

Example of the Data Collection Sheet for lesion recording
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